🇺🇸 Antiplatelet Drug in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 16 May 2025 – 16 May 2026
- Total reports: 10
Most-reported reactions
- Cardio-Respiratory Arrest — 1 report (10%)
- Completed Suicide — 1 report (10%)
- Death — 1 report (10%)
- Embolism — 1 report (10%)
- Flushing — 1 report (10%)
- Focal Segmental Glomerulosclerosis — 1 report (10%)
- Hepatic Cirrhosis — 1 report (10%)
- Hepatic Failure — 1 report (10%)
- Hypertensive Crisis — 1 report (10%)
- Immunotactoid Glomerulonephritis — 1 report (10%)
Antiplatelet Drug in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Antiplatelet Drug approved in United States?
Antiplatelet Drug does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antiplatelet Drug in United States?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.